Coronavirus information for Feinberg.

Continuing Medical Education Series

Advances and Updates in Urologic Oncology

Register for the Series

Join us for our virtual didactic lecture series on critical topics and innovations in genitourinary oncology.

Earn one AMA PRA Category 1 Credit(s)™ is available per session.

Led by Ashley E. Ross, MD, PhD, the conference takes place the third Thursday of the month following GU Oncology Conference at 5:30 pm CST. Dr. Ross is a surgeon-scientist at Northwestern University Feinberg School of Medicine and member of Robert H. Lurie Comprehensive Cancer Center at Northwestern University who specializes in urology and urologic oncology, and is a nationally recognized expert in prostate cancer. 

Find Upcoming Events In Our Series

Video Archive

Hypofractionated Radiation Treatment for Treatment of Prostate Cancer

Northwestern Medicine Radiation Oncologists, William Hartsell, MD, Nasir Mohammed, MD, MBA, Stephen Mihalcik, MD, PhD, and Adil Akthar, MD, discuss fractionation of radiation therapy treatment in prostate cancer.

Management of Recurring Prostate Cancer: Can Radiation Help?

Sean Sachdev, Assistant Professor of Radiation Oncology at the Feinberg School of Medicine at Northwestern University, discusses the use of radiation for the management of recurring prostate cancer.

PI3K/Akt Pathway Inhibition for the Treatment of Metastatic Castrate-Resistant Prostate Cancer

David VanderWeele, MD, PhD, Assistant Professor of Medicine (Hematology and Oncology) at Northwestern University Feinberg School of Medicine, discusses the PI3K/AKT pathway and its role in cancer, PI3K/AKT pathway alterations in prostate cancer, and inhibitors of the pathway and recent clinical trial results.

Small Molecule MYC Inhibitors for Cancer Therapy

Sarki Abdulkadir, MD, PhD, discusses his research on the MYC protein and its role in cancer treatment.

Updates on Management of Metastatic Hormone-Sensitive Prostate Cancer

Alicia Morgans, MD, MPH, discusses management options for patients with metastatic hormone-sensitive prostate cancer.

Bladder Cancer: Best of Journals

Shilajit Kundu, MD and Joshua Meeks, MD, PhD, discuss practice changing articles in bladder cancer.

Non-Radical Treatments for Prostate Cancer

Ashley Ross, MD, PhD, reviews sub-total glad therapies for prostate cancer, including patient selection and considerations, treatment selection and outcomes.

Management of Testis Cancer

Presented by the Polsky Urologic Cancer Institute at Northwestern Medicine, "Advances and Updates in Urologic Oncology" is a virtual didactic lecture series on critical topics and innovations in genitourinary oncology. In this video, Sia Daneshmand, MD, Professor of Urology and Director of Clinical Research at the University of Southern California, discusses the current management of testis cancer.

Enhancing Minority Recruitment and Participation in Clinical Trials

Adam Murphy, MD, MBS, MSCI, Assistant Professor of Urology, reviews factors that may influence minority recruitment and participation in clinical trials and presents strategies for increasing diversity in clinical trials.

Highlights in Urologic Oncology from ASCO 2021

David VanderWeele, MD, PhD, Assistant Professor of Medicine in Hematology/Oncology, reviews the clinical and translational GU oncology research presented during the 2021 ASCO annual meeting.

Prostate Biopsy Techniques: Ways to Optimize Cancer Detection and Ensure Patient Safety

Drs. Edward Schaeffer and Matthew Allaway discuss tools for optimizing prostate biopsy to enhance detection of clinically significant cancer and strategies to reduce morbidity for patients undergoing prostate biopsy.

Association of Inflammatory Bowel Disease and Prostate Cancer

Shilajit Kundu, MD, Professor of Urology at Northwestern Medicine describes the physiologic and genetic link between gut inflammation and prostate cancer risk, and potential targets that may be used in mitigating risk of inflammation induced tumorigenesis of the prostate.

Salvage Treatment for Prostate Cancer

Ashley Ross, MD, Professor of Urology at Northwestern Medicine discusses treatment plans for recurring prostate cancer also called second-line or salvage treatment.

Robotic Reconstruction of Complications in Urologic Oncology

Ziho Lee, MD, Assistant Professor of Urology at Northwestern Medicine discuss the contemporary use of robotic assistance in the treatment of complications following urologic oncologic procedures.

Advances in Urologic Oncology Conference PET Imaging in Prostate Cancer by Hatice Savas, MD

Hatice Savas, MD, Assistant Professor of Radiology, discusses current PET radiotracers that are used in prostate cancer imaging and newly approved PSME PET tracers.

Is there still a role for docetaxel in mHSPC?

Sweeney Christopher, MBBS, Medical Oncologist at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School describes treatment selections in metastatic hormone-sensitive prostate cancer (mHSPC).

Follow the Lurie Cancer Center on

Follow the Department of Urology on